STOCK TITAN

Insider at Nuvalent (NUVL) exercises options and sells 5,500 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nuvalent, Inc. Chief Development Officer Darlene Noci reported an exercise-and-sell transaction in Class A Common Stock. She exercised stock options to acquire 5,500 shares at $27.85 per share and sold 5,500 shares in open-market trades at a weighted average price of $123.51 per share.

The filing shows these transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2024. After the sale, she directly held 58,117 shares of Nuvalent Class A Common Stock.

Positive

  • None.

Negative

  • None.
Insider Noci Darlene
Role Chief Development Officer
Sold 5,500 shs ($679K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 5,500 $0.00 --
Exercise Class A Common Stock 5,500 $27.85 $153K
Sale Class A Common Stock 5,500 $123.51 $679K
Holdings After Transaction: Stock Option (Right to Buy) — 81,329 shares (Direct, null); Class A Common Stock — 63,617 shares (Direct, null)
Footnotes (1)
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.47 to $123.56, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Shares sold 5,500 shares Class A Common Stock sold in open market on June 29, 2026
Weighted average sale price $123.51/share Open-market sales in multiple trades on June 29, 2026
Option exercise price $27.85/share Stock Option (Right to Buy) for 5,500 shares
Shares acquired via option exercise 5,500 shares Class A Common Stock acquired by exercising derivative security
Post-transaction holdings 58,117 shares Direct Class A Common Stock ownership after sale
Option expiration date January 6, 2033 Expiration of Stock Option (Right to Buy)
Rule 10b5-1 plan adoption date November 18, 2024 Pre-arranged trading plan governing the transactions
Rule 10b5-1 trading plan regulatory
"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" with an exercise price of 27.85..."
Class A Common Stock financial
"security_title: "Class A Common Stock" for both sale and option exercise entries..."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
open-market sale financial
"transaction_action: "open-market sale" with transaction_code "S" for 5,500 shares..."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Noci Darlene

(Last)(First)(Middle)
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR

(Street)
CAMBRIDGE MASSACHUSETTS 02142

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Development Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/29/2026M(1)5,500A$27.8563,617D
Class A Common Stock06/29/2026S(1)5,500D$123.51(2)58,117D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$27.8506/29/2026M(1)5,500 (3)01/06/2033Class A Common Stock5,500$081,329D
Explanation of Responses:
1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.47 to $123.56, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
3. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
/s/ Nathan McConarty, attorney-in-fact07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Nuvalent (NUVL) Chief Development Officer Darlene Noci report in this Form 4?

Darlene Noci reported exercising options and selling shares of Nuvalent stock. She exercised 5,500 stock options at $27.85 per share and sold 5,500 Class A Common shares in open-market transactions at a weighted average price of $123.51 per share.

How many Nuvalent (NUVL) shares did the CDO sell and at what price?

The Chief Development Officer sold 5,500 Nuvalent Class A shares. The sales were executed in multiple open-market trades at prices ranging from $123.47 to $123.56, resulting in a weighted average sale price of $123.51 per share.

How many Nuvalent (NUVL) shares does Darlene Noci hold after the reported transactions?

After the reported transactions, Darlene Noci directly holds 58,117 shares. This figure reflects her Class A Common Stock position following the option exercise and corresponding sale of 5,500 shares disclosed in the Form 4 filing.

Were the Nuvalent (NUVL) insider transactions made under a Rule 10b5-1 plan?

Yes, the transactions were made under a Rule 10b5-1 trading plan. The filing states the plan was adopted by the reporting person on November 18, 2024, indicating the exercise-and-sell sequence was pre-arranged rather than timed discretionarily.

What stock option terms are disclosed in the Nuvalent (NUVL) Form 4?

The filing describes a stock option with a $27.85 exercise price. The option covers 5,500 shares of Class A Common Stock, expires on January 6, 2033, and vests in equal monthly installments over four years following January 6, 2023, subject to continued service.